B., Ascherio, A., Stampfer, M
Zhang Y, Ke Y, Zheng X, Liu Q, Duan X
The WHO accepts the growing evidence that GLP-1s can help reduce the risk of a range of serious and potentially fatal events and conditions including heart attacks and strokes, type 2 diabetes, high blood pressure, bad cholesterol, sleep apnoea and kidney and arterial disease
J Am Chem Soc 142:1955819569
Oral supplements and topical products may be available without a prescription, though physician guidance is still recommended
Because the ratio is fixed at manufacture, a researcher working with GLOW is always working with all three compounds simultaneously and cannot isolate the contribution of any one of them